January 11, 2018 / 6:45 AM / 5 months ago

BRIEF-Theranexus Announces Issuance Of European Patent Covering Its Drug Candidate THN102 For Treatment Of Narcolepsy and Parkinson's Disease ‍​

Jan 11 (Reuters) - THERANEXUS SA:‍​

* THERANEXUS ANNOUNCES ISSUANCE OF EUROPEAN PATENT COVERING ITS DRUG CANDIDATE THN102 FOR TREATMENT OF NARCOLEPSY AND PARKINSON’S DISEASE

* ‍RESULTS ARE EXPECTED IN Q2 OF 2019​

* ‍AT END OF 2017, LAUNCHED REGULATORY ACTIVITIES REQUIRED TO START NEW PHASE II CLINICAL TRIAL FOR THN102 IN 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below